Sage Journals: Discover world-class research

Abstract

Keywords

PML multiple sclerosis

Get full access to this article

View all access options for this article.

References

Pilz

Harrer

Wipfler

. Tumefactive MS lesions under fingolimod: A case report and literature review. Neurology 2013; 81(19): 1654–1658.

Yousry

Pelletier

Cadavid

. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012; 72(5): 779–787.

Wattjes

Vennegoor

Steenwijk

. MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry 2015; 86(7): 793–798.

Wijburg

Witte

Vennegoor

. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. Epub ahead of print 16 August 2016. DOI: 10.1136/jnnp-2016-313772.

Hodel

Outteryck

Dubron

. Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: Diagnostic precision with MR imaging. Radiology 2016; 278(3): 863–872.

Wattjes

Wijburg

Vennegoor

.; Dutch-Belgian natalizumab-associated PML study group. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. J Neurol Neurosurg Psychiatry 2016; 87(8): 879–884.

Sinnecker

Othman

Kühl

. 7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study. Neurol Neuroimmunol Neuroinflamm 2015; 2(6): e171.

Comment on extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?

Abstract

Keywords

Get full access to this article

References